A Brukinsa regimen has delivered a large progression-free survival (PFS) benefit in what BeOne Medicines called a “new ...
Klick Health has struck its third takeover in 18 months, snapping up Oxford PharmaGenesis to expand its global reach and ...
Four months after Theravance Biopharma shut down its R&D unit, laid off half its staff and signaled it was up for sale, the ...
Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...
In rejecting NASP, the FDA is delaying the launch of a gout drug that Sobi projected could reach up to 6 billion Swedish kroner ($620 million) in peak sales. (Photo by Sarah Silbiger/Getty Images) ...
Once the CHMP has delivered marketing authorization recommendations, final sign-off on the decisions must still be conferred ...
German generics maker Stada is back to business after being acquired by CapVest Partners last year, loading itself up with 16 ...
The transaction is a big splash for Merck KGaA, representing the company’s largest deal since its buyout of Sigma-Aldrich for ...
Bayer has scored a key victory in its defense against Roundup lawsuits as the U.S. Supreme Court has tossed a $1.25 million ...
The world’s first CAR-T therapy for solid tumors has passed muster in China, with the country's National Medical Products ...
The European Commission has kicked off formal proceedings in an antitrust investigation against Sanofi. The probe surrounds ...
In the past two weeks, CARsgen Therapeutics won the world's first regulatory approval for a solid tumor CAR-T Biologics' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results